Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease
Acquiring Company
Eton Pharmaceuticals
Acquired Company
Teva Pharmaceutical Industries Ltd
Deer Park
Tel AvivBiotechnologyHealthcareHealth CarePharmaceuticalManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Eton Pharmaceuticals, Inc. has successfully acquired Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. This strategic acquisition demonstrates Eton Pharmaceuticals' commitment to advancing treatment options for rare diseases, particularly in the case of Wilson Disease. Eton Pharmaceuticals plans to leverage its metabolic sales force to support healthcare professionals dedicated to treating Wilson Disease and will take over the commercialization of Galzin® within the United States. Additionally, the company has obtained the European rights to Galzin®, further expanding its reach and impact in the healthcare landscape.
Quick answer
Eton Pharmaceuticals is acquiring Teva Pharmaceutical Industries Ltd, announced January 5, 2025. Eton Pharmaceuticals is based in Deer Park, Illinois, United States.
- How much did Eton Pharmaceuticals pay for Teva Pharmaceutical Industries Ltd?
- The deal value was not disclosed.
- What does Eton Pharmaceuticals do?
- Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.
- Where are Eton Pharmaceuticals and Teva Pharmaceutical Industries Ltd based?
- Eton Pharmaceuticals is based in Deer Park, Illinois, United States. Teva Pharmaceutical Industries Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- Who are the decision-makers at Eton Pharmaceuticals?
- Fundz holds 1 contact at Eton Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie completes acquisition of Nimble Therapeutics to expand its immunology pipeline (January 23, 2025)
- AbbVie completes acquisition of Aliada Therapeutics to enhance neuroscience development (December 11, 2024)
- BioNTech completes acquisition of Biotheus to strengthen oncology strategy (February 4, 2025)
- Exicure, Inc. completes acquisition of GPCR Therapeutics USA Inc. to enhance its pipeline for cell and gene therapies (January 22, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
Who to call at Eton Pharmaceuticals, and when
When Eton Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eton Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eton Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eton Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eton Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Teva Pharmaceutical Industries Ltd?
Teva Pharmaceutical Industries Ltd was acquired by Eton Pharmaceuticals, based in Deer Park. The deal was reported on January 5, 2025. Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. Eton Pharmaceuticals is publicly traded (ETON) and operates in Biotechnology.
When did Eton Pharmaceuticals acquire Teva Pharmaceutical Industries Ltd?
Eton Pharmaceuticals's acquisition of Teva Pharmaceutical Industries Ltd was reported on January 5, 2025. Eton Pharmaceuticals, Inc. has successfully acquired Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Teva Pharmaceutical Industries Ltd do?
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of people worldwide. It is publicly traded (TEVA), operating in Manufacturing, and is based in Tel Aviv.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.